澳洋健康：终止全资子公司增资

Core Viewpoint - Aoyang Health (002172) has decided to terminate the capital increase plan for its wholly-owned subsidiary due to changes in the market environment, following discussions with the investment parties [1] Group 1 - The company originally planned to raise capital of 30.6 million yuan and 48.5 million yuan from Juxin Investment and Juliy Investment, respectively [1] - The decision to terminate the capital increase has been approved by the company's board of directors and the supervisory board, and it will be submitted for shareholder meeting approval [1] - The capital increase plan has not been substantively implemented, as no agreements were signed and no payments were made, meaning it will not have a significant impact on the company's operations [1]